SHANGHAI, Nov. 30, 2025 — On November 26, a significant Grade 5 fire swept through multiple residential buildings in Wang Fuk Court, Tai Po, Hong Kong. This severe incident resulted in considerable casualties and garnered widespread public attention. In response, Qiming Venture Partners announced a donation of HK$3 million on November 28 to the Tai Po Wang Fuk Court Aid Fund, established by the Hong Kong SAR Government, to assist affected residents and support the area’s reconstruction efforts.
The Hong Kong SAR Government initiated the Tai Po Wang Fuk Court Aid Fund on November 27, commencing with an initial allocation of HK$300 million. The fund’s objective is to coordinate social resources and provide comprehensive rescue and recovery support. It also welcomes public donations, aiming to consolidate broad community support for effective aid distribution. Qiming Venture Partners promptly contributed with this donation, thereby helping those impacted while fulfilling its corporate social responsibilities.
Qiming Venture Partners extends its deepest condolences to the families affected by the major fire and expresses profound respect for the frontline firefighters and rescue personnel. The firm is grateful for their exceptional professionalism and selfless dedication demonstrated throughout the crisis. Qiming hopes that its contribution will help alleviate the difficulties faced by residents and support their swift return to normal daily life. Qiming also urges other societal forces to participate in the relief efforts and contribute to the rebuilding of the impacted communities.
About Qiming Venture Partners
Qiming Venture Partners was established in 2006. Currently, the firm manages eleven US Dollar funds and seven RMB funds, with a total of $9.5 billion in capital raised. Since its inception, Qiming has invested in leading companies within the Technology and Healthcare industries during their early and growth stages.
Since its launch, Qiming has supported over 580 rapidly expanding and innovative companies. More than 210 of its portfolio companies have achieved successful exits through IPOs on exchanges such as the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or via mergers & acquisitions and other avenues. Furthermore, over 80 portfolio companies have attained unicorn or super unicorn status.
Many of Qiming’s portfolio companies are recognized as highly influential firms in their respective sectors today, including Xiaomi, Meituan, Bilibili, Zhihu, Roborock, HESAI, UBTech, WeRide, HyperStrong, Insta360, Unisound, Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, Schrödinger, APT Medical, Sanyou Medical, AmoyDx, SinocellTech, AusperBio, Yuanxin Technology, Insilico Medicine, Medilink Therapeutics, LaNova Medicines, zai, StepFun, among numerous others.